Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BlueJays9293on Oct 23, 2024 6:52pm
106 Views
Post# 36279380

RE:RE:RE:RE:The Buyout Window

RE:RE:RE:RE:The Buyout WindowIt was actually a bit of double entendre but I won't go into the risque part, because somebody on this board might start crying uncontrollably and throw a hissy fit.  But anyways, the main reason I posted that was to, in a lighthearted way, express that I feel with an absolute mortality benefit near 15%, Spectral could potentially be bought out for $5 usd. 

I also feel that it's within the realm of possibilities for this to happen before topline numbers are released.  But in the grand scheme of things, Spectral just needs to get back in the habit of putting up strong monthly enrollment numbers, and the rest will unfold accordingly.    
<< Previous
Bullboard Posts
Next >>